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Reactive Oxygen Species (ROS) are highly reactive molecules that can induce oxidative
stress. For instance, the oxidative burst of immune cells is well known for its ability to inhibit
the growth of invading pathogens. However, ROS also mediate redox signalling, which is
important for the regulation of antimicrobial immunity. Here, we report a crucial role of
mitochondrial ROS (mitoROS) in antifungal responses of macrophages. We show that
mitoROS production rises in murine macrophages exposed to swollen conidia of the
fungal pathogen Aspergillus fumigatus compared to untreated macrophages, or those
treated with resting conidia. Furthermore, the exposure of macrophages to swollen
conidia increases the activity of complex II of the respiratory chain and raises
mitochondrial membrane potential. These alterations in mitochondria of infected
macrophages suggest that mitoROS are produced via reverse electron transport (RET).
Significantly, preventing mitoROS generation via RET by treatment with rotenone, or a
suppressor of site IQ electron leak, S1QEL1.1, lowers the production of pro-inflammatory
cytokines TNF-a and IL-1b in macrophages exposed to swollen conidia of A. fumigatus.
Rotenone and S1QEL1.1 also reduces the fungicidal activity of macrophages against
swollen conidia. Moreover, we have established that elevated recruitment of NADPH
oxidase 2 (NOX2, also called gp91phox) to the phagosomal membrane occurs prior to the
increase in mitoROS generation. Using macrophages from gp91phox-/- mice, we have
further demonstrated that NOX2 is required to regulate cytokine secretion by RET-
associated mitoROS in response to infection with swollen conidia. Taken together,
these observations demonstrate the importance of RET-mediated mitoROS production
in macrophages infected with A. fumigatus.
Keywords: macrophages, reverse electron transport, reactive oxygen species, mitochondria, Aspegillus
fumigatus, cytokinesorg March 2021 | Volume 12 | Article 6414951
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Aspergillus fumigatus is a ubiquitous fungus that causes a wide
range of illnesses, from allergic reactions to life-threatening
invasive aspergillosis (1). Primary immunodeficiency is one of
the conditions that places individuals at risk of deadly invasive
aspergillosis (2). For instance, patients with chronic
granulomatous disease (CGD), who have mutations in genes
encoding the nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase complex, are highly susceptible to bacterial
and fungal infections including invasive aspergillosis (3, 4). The
lack of NADPH oxidase (NOX)-derived reactive oxygen species
(ROS) in CGD phagocytes results in the defective oxidative
killing of pathogens (3).
Besides being crucial for intracellular oxidative killing, ROS
can also orchestrate inflammatory processes in response to
microbial pathogens including fungi (5–7). Changes in ROS
levels are often a consequence of metabolic remodelling in
activated immune cells. Together these changes in cellular
metabolism and redox homeostasis can initiate, as well as
resolve, inflammatory responses (8–12). Indeed, a growing
number of investigations have shown that tuning the
production of specific inflammatory mediators, cytokines,
correlates directly with metabolic re-programming and altered
ROS production (9, 11).
There are numerous potential cellular sources of ROS, but the
mitochondrial respiratory chain complex I is known to be one of
the main contributors (13). ROS can be generated at complex I
via a specific mechanism called reverse electron transport (RET).
RET occurs when a significantly reduced coenzyme Q pool and a
large pH gradient across the mitochondrial inner membrane
drive electrons backwards through complex I resulting in
elevated superoxide production (14). Therefore, two types of
metabolic alterations can lead to RET. First, RET may occur
when the coenzyme Q pool becomes over-reduced with electrons
from respiratory chain complex II or glycerol-3-phosphate
dehydrogenase (9, 11, 14, 15). Second, a reduction in ATP
production by oxidative phosphorylation may promote the
increased membrane potential needed to sustain RET (9, 14).
The process of mitochondrial ROS (mitoROS) generation via
RET has been known for decades, but its physiological relevance
has been shown only recently (15). A growing body of evidence
indicates that RET occurs under physiological conditions and
that it drives redox signalling in a variety of processes in vivo.
Specific targets of RET-generated mitoROS remain unidentified,
but may include redox-sensitive proteins that are modified (andAbbreviations: MitoSOX, red mitochondrial superoxide indicator; mitoROS,
mitochondrial ROS; RET, reverse electron transport; NADPH, nicotinamide
adenine dinucleotide phosphate; NOX, NADPH oxidase; ELISA, enzyme-linked
immunosorbent assay; gp91phox-/-, NOX2 deficiency; ROS, reactive oxygen
species; CGD, chronic granulomatous disease; LPS, lipopolysaccharide; IL-1b,
interleukin-1b; TNF-a, tumor necrosis factor-a; CTCF, corrected total cell
fluorescence; BMDM, bone marrow-derived macrophages; MOI, multiplicity of
infection; GLRX1, glutaredoxin 1; SOD2, mitochondrial superoxide dismutase;
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; DHN, 1,8-
dihydroxynaphthalene; CI, complex I; CII, complex II; CS, citrate synthase;
NF-kB, nuclear factor-kB; DPI, diphenyleneiodonium chloride.
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generation of mitoROS by RET has been shown to be crucial
for survival under stress (16), oxygen sensing by the carotid body
(17), and control of inflammation (9, 11). In addition, although
high levels of ROS can promote aging by causing oxidative
damage to cellular components, increasing mitoROS
production specifically via RET extends Drosophila lifespan
(18). Therefore, identifying the mechanisms that trigger
mitoROS generation via RET and defining their targets will
improve our unders tand ing of phys io log i ca l and
pathophysiological signalling transduction, and may suggest
new avenues for therapeutic manipulation.
Previously, it was shown that macrophages stimulated by the
bacterial product lipopolysaccharide (LPS) shift their metabolism
from oxidative phosphorylation towards glycolysis, which has also
been associated with an increase in RET-induced mitoROS
production. In turn, mitoROS promote stabilization of the
transcription factor, hypoxia-inducible factor 1a, resulting in
elevation of interleukin (IL)-1b expression (9). It was recently
demonstrated that infection with A. fumigatus enhances glycolysis
in macrophages, which is required for efficient innate immune
responses (19). In this study, we have shown that mitoROS are
produced via RET in macrophages infected with swollen A.
fumigatus conidia and that this contributes to redox signalling
necessary for cytokine secretion and fungal growth inhibition. In
particular, we have found that blocking RET with a mitochondrial
inhibitor, rotenone, or an antioxidant, S1QEL1.1, prevents tumor
necrosis factor-a (TNF-a) and IL-1b secretion in murine
macrophages exposed to swollen fungal conidia. Furthermore,
both rotenone and S1QEL1.1 abolish the ability of macrophages
to inhibit growth of swollen conidia, while having no effect on their
ability to inactivate resting conidia. Moreover, we show that
enhanced recruitment of NOX2 (gp91phox) to phagosomes
occurs before the increase in mitoROS generation by infected
macrophages. Using macrophages from gp91phox-/- mice, we
have further established that NOX2 activity is essential for the
regulation of cytokine secretion via RET-derived mitoROS. Overall,
our work reveals a novel mechanism underlying the regulation of
antifungal responses of macrophages against Aspergillus infection.MATERIALS AND METHODS
Reagents
Red Mitochondrial Superoxide Indicator (MitoSOX) (M36008),
Pierce Trifluoroacetic Acid (TFA) (28904), dithiothreitol (DTT)
(R0862), zymosan (Z2849) were obtained from Thermo Fisher
Scientific. RPMI 1640 Medium, GlutaMAX (61870036), heat
inactivated Fetal Bovine Serum (HI-FBS) (10082147), HEPES
(1156049), EDTA (15575020), Phosphate-Buffered Saline (PBS)
(10010023), HBSS (14025-092) were purchased from Gibco.
Triton X-100 (X100), diamide (D3648), Triethylammonium
bicarbonate buffer (TEAB) (T7408), NaCl (S9888),
iodoacetamide (I1149), SDS (L3771), Tris(2-carboxyethyl)
phosphine hydrochloride (TCEP) (C4706), urea (U5378),
acetonitrile (ACN) (271004), HEPES (H4034), rotenone
(R8875), mitoTEMPO (SML0737), S1QEL1.1 (SML1948),March 2021 | Volume 12 | Article 641495
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Thiopropyl Sepharose 6B resin (17042001) was obtained from
GE Healthcare.
Cells and Preparation of A. fumigatus
Murine bone marrow-derived macrophages (BMDMs) were
obtained from C57BL/6J or gp91phox−/−mice, as described
previously (20). Cells were differentiated in RPMI 1640
Medium, GlutaMAX supplemented with 20% (v/v) L929 cell
supernatant, 10% (v/v) HI-FBS, 100 µg/ml penicillin, 100 µg/ml
streptomycin, and 10 mM HEPES. At least one night before
treatment, BMDMs were transferred into RPMI 1640 Medium,
GlutaMAX supplemented with 10% (v/v) HI-FBS (R10
medium). Alveolar macrophages were isolated from murine
bronchoalveolar lavage fluid obtained by washing the airways
with sterile PBS containing 5mM EDTA (21). Murine peritoneal
macrophages were harvested 4 days after intraperitoneal
injection of 3% (w/v) thioglycollate (BD Biosciences) by
washing the intraperitoneal cavity with sterile PBS containing
5mM EDTA (20). Isolated cells were plated in multi-well TC
culture plates in R10 medium and left to adhere for at least 4 h
with a subsequent washing off non-adherent cells.
A. fumigatus clinical isolate CBS 144-89 (CEA10) was used as
wild-type strain (22). To test a DHN melanin-deficient strain,
Dalb1(pksP1) was used (23). To prepare swollen conidia of A.
fumigatus, conidia were first grown in Sabouraud-dextrose
media for 3 h at 30 rpm to avoid clumping. Swollen conidia
were harvested, washed and re-suspended in R10 medium. To fix
swollen conidia, after swelling, they were treated with 10% (v/v)
formalin for 1 h at 4°C, subsequently washed with PBS and re-
suspended in R10 medium. To prepare heat-killed conidia, a
suspension of conidia in water were incubated at 90°C
for 30 min.
Measurement of Mitochondrial Reactive
Oxygen Species and NOX2 Localization
For fluorescence microscopy, 4x104 BMDMs in R10 medium
were inoculated into µ-Slide 8-well coverslip (ibidi) and
incubated at 37°C in 5% (v/v) CO2. Cells were then infected
with A. fumigatus or exposed to zymosan. 20 min before the end
of incubation, cells were stained with 5 mM MitoSOX in HBSS,
and then fixed with 10% (v/v) formalin. To evaluate NOX2
cellular localization, BMDMs were exposed to conidia, methanol
fixed and stained with gp91-phox Alexa Fluor 647 antibody
(Santa Cruz, sc-130543 AF647). Fluorescence was measured
using a DeltaVision fluorescent microscope. Images were
analyzed using ImageJ software and measuring the corrected
total cell fluorescence (CTCF). CTCF was calculated according to
the formula: CTCF = Integrated Density - (Area of selected cell x
Mean fluorescence of background readings). Brightness and
contrast adjustments are the same for all representative images.
Measurement of Mitochondrial Membrane
Potential
The mitochondrial transmembrane potential (DYm) was
assessed by the measurement of uptake of MitoView633Frontiers in Immunology | www.frontiersin.org 3(Cambridge Bioscience, BT70055) fluorescent probe that was
monitored fluorimetrically in a microplate reader (Tecan,
SPARK1933) with a far-red channel.
Cysteine Oxidation
BMDMs at a concentration of 2 × 106 cells/well in TC-treated
six-well cell culture plates were challenged with swollen A.
fumigatus conidia (MOI 5) for 2 h. After incubation,
macrophages were washed with PBS and samples were pre-
processed for an analysis of oxidative protein modifications as
described previously (24). Briefly, proteins were precipitated with
TCA, and protein pellets were dissolved in 300 µl lysis buffer
containing 1% (w/v) SDS, 150 mM NaCl, 100 mM TEAB, 4 mM
EDTA, 1 tablet of cOmplete Ultra Protease Inhibitor Cocktail
(Roche), and 100 mM iodoacetamide (IAM). After excess IAM
was removed with acetone, proteins were re-solubilized in 100
mM TEAB and reduced by the addition of 0.5 M TCEP (tris(2-
carboxyethyl)phosphine). Reduced proteins were captured on a
pre-conditioned Thiopropyl Sepharose 6B resin. After
incubation on the resin, unbound proteins were washed away
with the washing buffers in the following order: 8 M urea; 2 M
NaCl; 80% (v/v) ACN and 0.1% (v/v) TFA; and 25 mM HEPES.
To elute cysteine-containing proteins, resin was incubated with
25 mM NH4HCO3 buffer containing 20 mM DTT and
centrifuged at 1,500g for 1 min. Fractions were analyzed by
SDS-gel electrophoresis. Protein concentration in each sample
was determined by Bradford assay (25). Equal amounts of
proteins were loaded and separated on NuPAGE 4–12% Bis-
Tris Gel (Invitrogen) and gels were stained by silver staining kit
(Thermo Scientific, 24612). SeeBlue Plus2 (Invitrogen, LC5925)
was used as a marker. Western blot analysis was performed to
evaluate the level of thiol modifications in GAPDH. MagicMark
XP (Invitrogen, LC5602) was used as marker for western blots.
Mitochondrial Respiratory Chain Assays
and Evaluation of Protein Expression
Levels
BMDMs were plated at 2 × 106 cells/well in non-treated six-well cell
culture plates, challenged with A. fumigatus at MOI of 5 and plates
were subsequently spun at 400g for 2 min. After incubation for 2 h,
cells were washed with PBS and put on ice. Cells were harvested and
centrifuged at 1000 g for 10 min at 4°C and frozen in liquid
nitrogen. After cells were quickly thawed at 37°C, samples were
dissolved in PBS containing cOmplete Ultra Protease Inhibitor
Cocktail (Roche) and homogenized with a 50-ml Hamilton
syringe (Sigma, 58382) by taking up and expelling the suspension
several times until it appeared as a homogeneous solution.
Homogenate was kept on ice for the immediate measurement
enzymatic activities. Enzymatic activity of respiratory chain
complexes was performed as previously described with a
spectrophotometer Spark plate reader (26). Cell homogenates
were also used to evaluate the abundance of proteins in BMDMs
treated with swollen conidia of A. fumigatus. Extracted proteins
were analyzed by western blot with anti-GAPDH (Abcam,
ab181602), anti-GLRX1 (R&DSystems, AF3119), anti-SOD2
(Abcam, ab13533) or NOX2 (Abcam, ab129068) antibodies.March 2021 | Volume 12 | Article 641495
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Macrophages were plated at 4 × 105 cells/well in TC-treated 48-
well cell culture plates and left to adhere overnight. Cells were
subsequently incubated with swollen A. fumigatus conidia (MOI
5). Zymosan (MOI 5) was given where indicated. 2 µM
diphenyleneiodonium chloride (DPI) was added for 1 h to
inhibit NADPH oxidase complex. 2.5 µM rotenone or 12 µM
FCCP were added 1 h before challenge. 0.5 mM MitoTEMPO, 5
µM S1QEL1.1, or 5 µM S3QEL2 were added to macrophages for
the whole period of incubation with swollen conidia.
Supernatants from macrophages were collected at 14 h
(overnight) after stimulation. IL-1b (DY401) and TNF-a
(Dy410) ELISA kits from R&DSystems were used according to
the manufacturer’s instructions. To assess killing capacity,
macrophages were plated at 5 × 104 cells/well in TC-treated
96-well cell plates and incubated with conidia at MOI of 3 for
resting conidia and MOI of 1 for swollen conidia. Following
incubation for 4 hours, cells were lysed and the viability of
remaining conidia was determined with resazurin assay (27).
Statistical Analyses
RStudio was utilized to perform data analyses and visualization.
The following packages were used: base (28), car (29), data.table
(30), ggplot2 (31), ggpubr (32), rstatix (33), plyr (34), carData
(35). To test whether obtained data were normally distributed the
Shapiro-Wilk test was performed. Levene’s test was used to
assess homogeneity of variance. Statistical significance was
evaluated either with the unpaired standard Student’s or
Welch’s t-test or Mann Whitney U Test. The false discovery
rate (FDR) adjustment of the p values was implemented using
the Benjamini-Hochberg method (36). Multiple groups were
compared either with the Kruskal-Wallis test or Welch’s one-
way ANOVA or one-way ANOVA, all followed by Tukey post-
hoc tests. * indicates p<0.05, ** indicates p<0.01, ***
indicates p<0.001.RESULTS
Sensing Swollen A. fumigatus Conidia
Induces MitoROS in Macrophages
Recently, it was proposed that mitoROS, produced specifically
through RET, transform activated macrophages into a pro-
inflammatory state (9). However, it was not known whether
the recognition of fungal cells, or fungal cell wall components,
induces the increased mitoROS production in macrophages.
Therefore, our first objective was to test whether macrophages
infected with the fungal pathogen A. fumigatus display increased
mitoROS generation. Interestingly, using mitoSOX as a
fluorescent probe for mitoROS, we observed that resting
conidia of A. fumigatus did not impact mitoROS production
by BMDMs after a short-term co-incubation of 2 h (Figures 1A,
B). In contrast to resting conidia, infection with germinating
(swollen) conidia of the fungus for the same period led to
elevated mitoROS production in macrophages (Figures 1A, B).Frontiers in Immunology | www.frontiersin.org 4The mitochondrial inhibitor rotenone is known to prevent
mitoROS generation during RET (13, 37, 38) (Figure 1F), and
therefore we tested the effect of treating BMDMs with rotenone
before exposure to swollen conidia. Pre-treatment with rotenone
for 1 h significantly inhibited the increase in mitoROS normally
observed following exposure of BMDMs to swollen A. fumigatus
conidia (Figures 1A, C). This was consistent with our prediction
that A. fumigatus triggers elevated mitoROS generation in
macrophages via RET.
As rotenone is a metabolic inhibitor, and therefore its potential
toxicity could conceivably have accounted for the observed
reduction in mitoROS production in infected macrophages.
However, the rotenone concentration used (2.5 µM) did not alter
viability of macrophages (Figure 1D). Even a 4-fold increase in
rotenone concentration did not affect metabolic activity of BMDMs
after a 1 h exposure (Figure 1D). In addition, mitochondrial
membrane potential was not affected by rotenone (Figure 1E),
suggesting that a short-term pre-treatment of BMDMs with 2.5 µM
rotenone did not interfere with a mitochondrial potential-
dependent accumulation of probes such as MitoSOX. These
observations are consistent with a previous report about the dose-
and time-dependent toxicity of rotenone (39). Therefore, the impact
of this short-term pre-treatment of BMDMs with 2.5 µM rotenone
supports the idea that A. fumigatus activates RET-mediated
mitoROS production.
RET is characterized by a considerably reduced coenzyme Q
pool and a subsequent transfer of electrons from coenzyme Q to
complex I, and the increased activity of mitochondrial complex
II can contribute to the excessive reduction of the coenzyme Q
pool (Figure 1F). Therefore, we hypothesized that the elevated
activity of complex II could facilitate mitoROS production via
RET in fungi-challenged macrophages. As predicted, we found
that the activity of complex II increased when BMDMs were
treated with swollen conidia of A. fumigatus, compared to
unstimulated BMDMs (Figure 1G). Furthermore, the activity
of complex II was not affected by resting conidia, which were
consistently unable to induce elevated mitoROS levels (Figures
1A, B). These data support the idea that complex II drives
mitoROS production via RET.
Mitochondrial complex I is the site for mitoROS production
via RET (Figure 1F), and the activity of this complex can be
decreased due to inhibition by mitoROS produced at that site.
Thus, the reduced activity of this complex is another indicator of
RET taking place (38). Interestingly, when we measured the
activity of complex I in infected cells, we could only detect a
slight reduction in the complex I activity that was not statistically
significant in BMDMs exposed to swollen conidia (Figure 1G).
Increased mitochondrial membrane potential, which occurs due
to a reduction in ATP production by oxidative phosphorylation, can
contribute to and help to sustain RET. We used MitoView633 to
monitor mitochondrial membrane potential in infected BMDMs, as
the mitochondrial accumulation of MitoView633 and its
subsequent fluorescence are dependent on the membrane
potential. To prevent overgrowth of the fungus during overnight
co-incubation with BMDMs, we used inactivated conidia in this
experiment. Consistent with our previous results, the mitochondrialMarch 2021 | Volume 12 | Article 641495




FIGURE 1 | Sensing swollen conidia of A. fumigatus induces mitoROS production and increases the activity of the respiratory chain complex II and mitochondrial
transmembrane potential. (A) Microscopic analysis of mitoROS in BMDMs infected with resting or swollen conidia of A. fumigatus. BMDMs were incubated with
either resting or swollen A. fumigatus conidia for 2 h, stained with mitoSOX, fixed and subjected to imaging. Treatment with menadione was used as a positive
control. To prevent mitoROS production through RET, BMDMs were treated with rotenone (shown with yellow background) for 1 h prior to exposure of BMDMs to
swollen conidia. The scale bars are 5 µm. (B, C) The quantification of the level of fluorescence in infected macrophages. The abundance of mitoROS in BMDMs was
determined by image analysis of MitoSOX-stained BMDMs with ImageJ software. A relative corrected total cell fluorescence (CTCF) was calculated in relation to an
average of CTCF measured in untreated (Control) BMDMs (B) or in BMDMs exposed to swollen conidia (C). (D) Measurement of viability of BMDMs after a short-
term treatment with rotenone. Viability of BMDMs measured with the resazurin assay after 1 h of exposure to rotenone followed by 2 h cultivation in R10 media and
is expressed in comparison to untreated cells (Control). (E) Analysis of mitochondrial membrane potential after treatment of BMDMs with rotenone. MitoView633-
associated fluorescence was measured in BMDMs following 1 h of exposure to 2.5 µM rotenone followed by 2 h cultivation in R10 media containing fluorescent
probe and represented mitochondrial membrane potential. Relative mitochondrial membrane potential was calculated in relation to an average of fluorescence units
measured in untreated (Control) cells. (F) Schematic of mitoROS production via reverse electron transport (RET) in mitochondria. Coenzyme Q (Q) becomes over-
reduced with electrons supplied by complex II (CII) during succinate oxidation. A large membrane potential and pH gradient drive electrons from coenzyme Q to
complex I (CI) resulting in superoxide (O2
.-) production at one of CI sites. Rotenone inhibits RET-induced mitoROS generation. (G) Spectrophotometry analysis of
enzyme activities of mitochondrial respiratory chain complex I (CI), complex II (CII), and citrate synthase (CS). BMDMs were left untreated (Control) or exposed to
resting or swollen conidia of A. fumigatus for 2 h. Enzymatic activity measured in untreated BMDMs was set as 100% in each replicate. The activity of citrate
synthase was measured to assess quality of mitochondria. (H) Measurements of mitochondrial membrane potential in BMDMs by detecting fluorescence of
MitoView633. BMDMs were exposed to heat-inactivated resting or formalin-fixed swollen conidia in the presence of MitoView633. MitoView633-associated
fluorescence was measured after incubation overnight. Treatment with 18 µM FCCP (p-trifluoromethoxyphenylhydrazone) was used as a negative control. Data are
from two (D, E, H), three (B, C), or four (G) independent experiments. “n” indicates number of cells used for quantification; bars indicate means and standard errors.
Statistical significance was calculated with the Kruskal-Wallis test followed by Tukey post-hoc tests (B, H), with the Mann Whitney U Test (C), or Student’s (D, E)
t-test, or one-way ANOVA followed by Tukey post-hoc tests (G): * indicates p<0.05, and ** indicates p<0.01.Frontiers in Immunology | www.frontiersin.org March 2021 | Volume 12 | Article 6414955
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swollen conidia, but not following exposure to resting conidia
(Figure 1H).
Next, as A. fumigatus infection is associated with increased
mitoROS (Figures 1A–C), we tested whether infection affects the
redox status of endogenous BMDM proteins. To achieve this, we
assessed the levels of reversibly oxidized proteins in macrophages
infected with swollen conidia of A. fumigatus. Proteins were
extracted from BMDMs and pre-processed according to the
scheme in Supplemental Figure 1A. This method allowed us to
capture proteins containing oxidized cysteines, which are the
primary targets of ROS. This analysis of thiol oxidation showed
that exposing macrophages to the fungus promoted oxidative
post-translation modifications in the immune cells
(Supplementary Figure 1B). We also tested whether the high
mitoROS in fungus-activated BMDMs induces oxidative stress by
evaluating the abundance of two antioxidant proteins: cytosolic
glutaredoxin 1 (GLRX1) and mitochondrial superoxide dismutase
(SOD2). The expression of neither protein was increased following
exposure to swollen A. fumigatus conidia, as measured by western
blotting (Supplementary Figures 1C, D) suggesting no significant
exposure to oxidative stress.
Removal of a Melanin or Protein
Layer From Dormant A. fumigatus
Conidia Does Not Induce MitoROS in
Infected Macrophages
We speculated that DHN melanin on the surface of dormant A.
fumigatus could prevent recognition of immunogenic
components of the fungal surface required to initiate RET.
Therefore, to investigate why resting conidia do not induce
mitoROS via RET in macrophages, we exposed BMDMs to
resting conidia of a A. fumigatus DpksP strain, which lacks the
DHN melanin layer (23). Interestingly, we observed neither an
increase in mitoROS levels (Figures 2A, B) nor a significant
alteration in the activities of complex I or complex II, or in
mitochondrial membrane potential in macrophages infected
with this DHN melanin-deficient strain (Figures 2C, D).
Next, we tested whether proteins on the conidial surface could
block the sensing of immunogenic fungal molecules that initiate
mitoROS production via RET (40). Surface proteins were degraded
by heating and heat-treated resting conidia were added to BMDMs.
However, no changes in mitoROS production (Figures 2A, B) or in
the mitochondrial activities and membrane potential were observed
in macrophages following incubation with heat-killed resting
conidia (Figure 2C, and Figure 1H). Overall, these data suggest
that only germinating (swollen) A. fumigatus conidia are able to
induce RET.
Inhibition of RET in Macrophages
Exposed to Swollen A. fumigatus Conidia
Reduces Cytokine Secretion and
Fungicidal Capacity
The secretion of pro-inflammatory cytokines such as TNF-a and
IL-1b helps to develop host resistance to A. fumigatus infections
and mediate antifungal immune responses (41, 42). Therefore,Frontiers in Immunology | www.frontiersin.org 6we tested whether blocking RET-mediated mitoROS production
affects the ability of macrophages to secrete these cytokines in
response to fungal invasion. Murine macrophages were pre-
treated with rotenone for 1 h and exposed to swollen A.
fumigatus conidia. We confirmed the importance of mitoROS
for antifungal responses in bone marrow derived, alveolar, and
peritoneal macrophages, as blocking mitoROS with rotenone
resulted in reduced secretion of TNF-a and IL-1b by all three
types of macrophages infected with swollen conidia (Figures 3A,
B). This suggests a universal function of RET-associated
mitoROS signalling in the antifungal responses of macrophages.
To confirm that the effect of rotenone is primarily due to its
ability to suppress mitoROS production via RET, we tested
whether other inhibitors of RET affect cytokine secretion in A.
fumigatus-stimulated BMDMs. Accordingly, carbonyl cyanide p-
trifluoromethoxyphenylhydrazone (FCCP), which is known to
prevent RET by altering mitochondrial membrane potential (14),
significantly reduced cytokine secretion in infected BMDMs
(Figures 3C, D). Also, S1QEL1.1, an antioxidant that
suppresses mitoROS via RET (43), decreased TNF-a and IL-1b
production by BMDMs exposed to swollen conidia. In contrast,
other mitochondrial antioxidants, S3QEL2 and mitoTEMPO,
which act independently of RET suppression (44), did not affect
TNF-a secretion by BMDMs exposed to swollen conidia
(Figures 3C, D). Taken together, these observations strongly
suggest that preventing RET-mediated mitoROS generation
impairs the cytokine responses of macrophages.
Next, we tested whether mitoROS production is necessary for
macrophages to inhibit A. fumigatus growth. Interestingly,
compounds with potential to suppress RET, namely rotenone,
FCCP and S1QEL1.1, reduced the capacity of macrophages to
inhibit growth of swollen conidia (Figure 3E). In contrast, the
antioxidants S3QEL2 and mitoTEMPO, which do not affect RET,
did not alter the fungicidal function of BMDMs against swollen
conidia (Figure 3E). Interestingly, the RET inhibitors did not
attenuate the inhibitory capacity of macrophages against resting
conidia (Figure 3F). This is entirely consistent with our
observation that resting conidia do not induce RET-mediated
mitoROS generation (Figures 1A, B, G, H). Therefore, mitoROS
that originate specifically from RET mediate cytokine secretion
and are required to inhibit growth of swollen conidia, but are
dispensable for the fungicidal function against resting conidia.
Sensing b-Glucan or Viability-Associated
Molecules Does Not Induce MitoROS
via RET
The recognition of microbial ligands by various receptors is
required to initiate immune responses and antimicrobial
signalling (45). Currently, little is known about the ligands that
induce inflammatory responses through RET-associated
mitoROS signalling. Since we only observed RET and elevated
mitoROS generation in BMDMs infected with swollen conidia,
we reasoned that RET might be triggered by b-glucan, a major
carbohydrate of the cell wall of swollen A. fumigatus conidia.
Interestingly, macrophages activated by zymosan particles, a
fungal cell wall-derived product composed mainly of b-glucan,March 2021 | Volume 12 | Article 641495
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staining (Figures 4A, B). However, the increase in mitoROS was
not statistically significant and was not inhibited by rotenone
(Figures 4A–C), suggesting that the mitoROS observed upon
zymosan stimulation was not generated via RET. This correlated
well with the observation that zymosan was unable to elevate
complex II activity required for RET (Figure 4E) and that
rotenone had no effect on TNF-a and IL-1b secretion when
BMDMs were activated by zymosan (Figures 4F, G). Therefore,
b-glucan recognition is not sufficient to trigger RET-mediated
mitoROS production.
The metabolic reprogramming of macrophages, which could
lead to mitoROS production via RET, takes place when immune
cells are infected with live E.coli, whereas heat-killed bacteria do
not have this effect upon macrophage metabolism (10). This may
indicate that viability-associated molecules like microbial mRNA
can induce metabolic reprogramming required for RET in
immune cells (46). Thus, we also tested whether this “viability-
specific” immune response triggers mitoROS in A. fumigatus-
infected macrophages. Surprisingly, while heat-killed swollen
conidia did not induce mitoROS, and even reduced their levels,
infection with formalin-fixed swollen conidia led to an increase in
mitoROS generation in BMDMs (Figures 4A, B). This elevation
in mitoROS was abolished upon pre-treatment with rotenone,
confirming that fixed germinating conidia can induce RET-
associated mitoROS (Figure 4D). Furthermore, rotenone
treatment reduced the production of TNF-a and IL-1b by
macrophages challenged with fixed swollen conidia (Figures 4F,
G). Meanwhile, heat-killed swollen conidia did not stimulate
cytokine secretion by macrophages, which was consistent with
their inability to initiate mitochondria redox signalling (FiguresFrontiers in Immunology | www.frontiersin.org 74F, G). These data indicate that the regulation of cytokine
production by RET does not depend upon sensing viability-
associated molecules. Therefore, recognition of the cell surface of
swollen conidia, is probably required for the induction of RET-
mediated mitoROS production.
NADPH Oxidase 2 Is Required for
MitoROS Production via RET in A.
fumigatus-Stimulated Macrophages
It was suggested previously that NADPH oxidases could affect
mitochondrial function and particularly mitoROS production,
and vice versa (47, 48). Also, the infection-associated metabolic
reprogramming of macrophages requires the activity of the
NOX2 complex (10). However, it is not known whether NOX2
(gp91phox) activity is required to initiate RET-associated
mitoROS generation in activated immune cells. Therefore, we
tested whether infecting macrophages with swollen conidia
induces a simultaneous increase in NOX2 phagosomal
accumulation and mitoROS production. Interestingly, during
first hour of co-incubation of BMDMs with swollen conidia,
there was enhanced recruitment of NOX2 to phagosomal
membranes (Figures 5A, B). During this period mitoROS was
not elevated in infected cells, but mitoROS generation did follow
after 1.5 h of infection (Figure 5C). Therefore, NOX2 activation
precedes enhanced mitoROS production. We then tested
whether the increase in mitoROS is associated with changes in
NOX2 abundance rather than its recruitment to the phagosome.
However, both western blot and microscopic analyses revealed
no detectable alterations in NOX2 protein abundance after 2 h of
infection, during which time mitoROS levels were increased
(Figures 5D–F). Therefore, enhanced NOX2 phagosomalA B C D
FIGURE 2 | Detection of melanin-deficient or heat-killed resting A. fumigatus conidia by BMDMs does not induce mitoROS or alter the activity of mitochondrial
complexes I and II, and mitochondrial transmembrane potential. (A) Microscopic analysis of mitoROS in BMDMs. BMDMs were left untreated (Control) or infected
with conidia lacking DHN melanin (pksp) or heat-killed (HK) resting A. fumigatus conidia for 2 h. Cells were stained with mitoSOX, fixed and subjected to imaging.
The scale bars are 5 µm. (B) The abundance of mitoROS in BMDMs was determined by image analysis of MitoSOX-stained BMDMs with ImageJ software. A relative
corrected total cell fluorescence (CTCF) was calculated in relation to an average of CTCF measured in untreated (Control) BMDMs. (C) Spectrophotometry analysis
of enzyme activities of mitochondrial respiratory chain complex I (CI), complex II (CII), and citrate synthase (CS). BMDMs were left untreated (Control) or exposed to
resting or heat-killed resting conidia for 2 h. Enzymatic activity measured in untreated BMDMs was set as 100% in each replicate. The activity of citrate synthase was
measured to assess quality of mitochondria. (D) Measurements of mitochondrial membrane potential in BMDMs by detecting fluorescence of MitoView633. BMDMs
were exposed to pksp resting conidia. MitoView633 fluorescence was measured after incubation overnight. Data are from two (B, D), or three (C) independent
experiments. “n” indicates number of cells used for quantification; bars indicate means and standard errors. Differences between groups were evaluated with the
one-way ANOVA.March 2021 | Volume 12 | Article 641495
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FIGURE 3 | Suppression of RET-induced mitoROS reduces cytokine secretion and the ability to inhibit growth of swollen A. fumigatus conidia by murine
macrophages. (A, B) Evaluation of cytokine secretion by infected macrophages. Bone marrow-derived macrophages (BMDMs), alveolar or peritoneal macrophages
were treated either with vehicle (acetone) or rotenone for 1 h, after washing, macrophages were exposed to swollen A. fumigatus conidia and the supernatant was
collected after incubation overnight. Levels of TNF-a (A) and IL-1b (B) in supernatants were analyzed by ELISA. (C, D) BMDMs were ether treated with vehicle
(acetone or DMSO), rotenone, or FCCP for 1 h. After compounds were removed, BMDMs were treated with swollen A. fumigatus conidia. Antioxidants S1QEL1.1,
S3QEL2, or mitoTEMPO were added together with conidia. Following incubation overnight, supernatants were collected to measure cytokine levels by ELISA. No
cytokines were detected in the supernatant from cells treated with tested compounds, but not treated with swollen conidia (not shown). (E, F) BMDMs were ether
treated with vehicle (acetone or DMSO), rotenone, or FCCP for 1 h. After compounds were removed, BMDMs were treated with swollen or resting A. fumigatus
conidia. Antioxidants S1QEL1.1, S3QEL2, or mitoTEMPO were added together with conidia where indicated. After incubation for 4 h, macrophages were lysed with
water containing Triton X-100, and the growth of A. fumigatus was measure by a metabolic activity assay based on resazurin. The metabolic activity of A. fumigatus
conidia that were not exposed to BMDMs was set to 100%. Data are from two (A, B) (except for values for peritoneal macrophages, that were obtain from one
experiment), or three (C–F) independent experiments. Bars indicate means and standard errors, red rhomb represent means. Statistical significance was calculated
with the Welch’s t-test (A, B), one-way ANOVA (C–E) or Welch’s one-way ANOVA (F) followed by Tukey post-hoc tests: ** indicates p<0.01, and *** indicates
p<0.001.Frontiers in Immunology | www.frontiersin.org March 2021 | Volume 12 | Article 6414958
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mitoROS generation. Interestingly, the induction of the elevated
mitoROS generation were not depended on the uptake of swollen
conidia as the majority of conidia were engulfed during the first
0.5 h of infection (Figure 5G).Frontiers in Immunology | www.frontiersin.org 9Remarkably, NOX2 deficient BMDMs (gp91phox-/-)
exhibited higher basal levels of mitoROS in a resting state
compared to wild-type BMDMs (Figures 6A, B). However,
following challenge with swollen conidia, gp91phox-/-





FIGURE 4 | Sensing fixed swollen A. fumigatus conidia but not zymosan or heat-killed swollen conidia induces mitoROS production via RET in BMDMs.
(A) Microscopic analysis of mitoROS in BMDMs. BMDMs were left untreated (Control) or exposed to zymosan particles, heat-killed (HK) or formalin-fixed swollen
conidia of A. fumigatus. Cells were stained with mitoSOX, fixed and subjected to imaging. Where indicated, BMDMs were pre-treated with rotenone (shown with
yellow background) for 1 h. The scale bars are 5 µm. (B–D) The abundance of mitoROS in BMDMs was determined by image analysis of MitoSOX-stained BMDMs
with ImageJ software. A relative corrected total cell fluorescence (CTCF) was calculated in relation to an average of CTCF measured in untreated (Control) BMDMs
(B) or in BMDMs exposed to zymosan (C) or formalin-fixed swollen conidia (D). (E) Spectrophotometry analysis of enzyme activities of mitochondrial respiratory
chain complex I (CI), complex II (CII), and citrate synthase (CS). Enzymatic activity measured in untreated BMDMs were set as 100% in each replicate. The activity of
citrate synthase was measured to assess quality of mitochondria. (F, G) Evaluation of cytokine secretion in stimulated macrophages. After treatment with either
vehicle or rotenone, BMDMs were exposed to zymosan particles, heat-killed (HK sw) or formalin-fixed (Fixed sw) swollen conidia of A. fumigatus. Levels of TNF-a
and IL-1b in supernatants were analyzed by ELISA. Data are from two (B–D, F, G), or three (E) independent experiments. “n” indicates number of cells used for
quantification; bars indicate means and standard errors, red rhomb represent means. Statistical significance was calculated with the Kruskal-Wallis test followed by
Tukey post-hoc test (B), Mann Whitney U Test (C, D), or Student’s t-test (E–G): ** indicates p<0.01, and *** indicates p<0.001.March 2021 | Volume 12 | Article 641495
Hatinguais et al. MitoROS Macrophages Antifungal Responsescellular fluorescence (Figures 6A–C). Also, rotenone did not
influence mitoROS levels in stimulated NOX2-deficient cells
(Figures 6A, B). Accordingly, inhibition of RET with rotenone
did not affect cytokine secretion in stimulated gp91phox-/-
BMDMs, suggesting that RET did not occur in those cells
(Figures 6D, E).
To examine the role of NADPH oxidase and associated
mitoROS in inhibition of A. fumigatus growth by immune
cells, we treated macrophages with diphenyleneiodoniumFrontiers in Immunology | www.frontiersin.org 10(DPI), an NADPH oxidase inhibitor (49). First, we confirmed
that as in NOX2-deficient cells, cytokine levels were not
significantly affected by rotenone in DPI-treated BMDMs
exposed to swollen conidia (Supplementary Figure 2A).
Furthermore, the inhibitors of RET-mediated mitoROS,
rotenone and S1QEL1.1, did not change the fungicidal activity
of DPI-treated macrophages infected either with resting or
swollen conidia (Supplementary Figures 2B, C). This





FIGURE 5 | Recruitment of gp91phox to phagosomes occurs prior to the increase in mitoROS production. (A) Microscopic analysis of gp91phox localization in
BMDMs. Cells were treated with swollen A. fumigatus conidia for an indicated period of time, fixed, stained with gp91phox antibodies, and subjected to imaging. The
scale bars are 10 µm. (B) Quantification of the phagosomal enrichment of gp91phox in BMDMs following infection with swollen conidia. (C) The abundance of
mitoROS in BMDMs was determined by image analysis of MitoSOX-stained BMDMs with ImageJ software. Corrected total cell fluorescence (CTCF) in infected cells
was normalized to an average of CTCF measured in untreated (control) cells. Means of CTCF for each time point were compared. (D) Western blot analysis of
protein abundance in untreated (Control) and infected for 2 h with swollen conidia BMDMs. Proteins were extracted from macrophages and analyzed by western blot
with anti-gp91phox or GAPDH antibodies. (E) Quantification of intensity of corresponding bands on blots as shown on (D) from independent experiments. Images
were analyzed in ImageJ. After background was subtracted, image was inverted and integrated density of each band was measured. Values were normalized to the
integrated density from the corresponding lanes. Data presented in relation to a band intensity for GAPDH measured in each experiment. (F) Total cellular levels of
gp91phox in untreated (Control) and exposed to swollen conidia for 2 h macrophages. A relative CTCF was calculated in relation to an average of CTCF measured in
untreated (Control) BMDMs. (G) Uptake of swollen conidia by BMDMs was calculated by counting an average number of conidia per macrophage and was
expressed as a percentage of the initial inoculum where MOI was set to 100%. Data are from two (B, C, F), or three (E, G) independent experiments. “n” indicates
number of phagosomes (B) or cells (C, F, G) used for quantification; bars indicate means and standard errors. Statistical significance was calculated with the one-
way ANOVA (B, G), Kruskal-Wallis test followed by Tukey post-hoc test (C), or t-test (E, F): * indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001.March 2021 | Volume 12 | Article 641495
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observed impact of FCCP, which disrupts mitochondrial
membrane potential, suggested that mitochondria might be
depolarized without a functional NADPH oxidase. Evidently,
additional depolarization caused by FCCP negatively affected the
fungicidal activity of BMDMs (Supplementary Figures 2B, C).
To further examine the importance of NADPH oxidase and
downstream mitoROS signalling via RET, we prolonged
incubation of BMDMs with swollen conidia. Then, we
discovered that after 6 h of infection, about 14% of fungalFrontiers in Immunology | www.frontiersin.org 11growth was inhibited by control macrophages, while only 7%
of fungal growth was inhibited by DPI-treated macrophages,
which was consistent with the previous report on alveolar
macrophages (50). This suggested that while untreated
macrophages could stop fungal proliferation, macrophages
with the inhibited NADPH oxidase failed to prevent A.
fumigatus growth. This confirmed the role of NADPH oxidase
in sustained fungal growth inhibition by macrophages.
In summary, NOX2 defects prevent RET-associated mitoROS
production and disrupt anti-Aspergillus functions of macrophagesA
D E F
B C
FIGURE 6 | Regulation of cytokine secretion by mitoROS relies on the presence of NOX2 (gp91phox). (A) Microscopic analysis of mitoROS in BMDMs from wild-
type (wt) or NOX2-deficient (gp91phox-/-) mice. Cells were either left untreated (Control) or infected with swollen A. fumigatus conidia for 2 h, stained with mitoSOX,
fixed and subjected to imaging. Where indicated, BMDMs were pre-treated with rotenone (shown with yellow background) for 1 h. The scale bars are 5 µm. (B) The
abundance of mitoROS in BMDMs was determined by image analysis of MitoSOX-stained BMDMs with ImageJ software. Means of CTCF for each condition were
compared. (C) MitoSOX CTCF was measured in untreated (Control) gp91phox-/- BMDMs and those exposed to swollen conidia for 2 h. A relative CTCF was
calculated in relation to an average of CTCF measured in untreated (Control) gp91phox-/- BMDMs. (D, E) Evaluation of cytokine secretion by infected NOX2-deficient
(gp91phox-/-) BMDMs. Macrophages were infected with swollen conidia and supernatants were collected after incubation overnight. Levels of TNF-a and IL-1b in
supernatants were analyzed by ELISA. No cytokines were detected in the supernatant from BMDMs (gp91phox-/-) treated rotenone, but not treated with swollen
conidia (not shown). (F) Schematic of the regulation of antifungal responses in macrophages through NOX2 complex and RET-associated mitoROS production. 1.
Following infection with swollen conidia, gp91phox is recruited to the phagosomal membrane. 2. MitoROS production is increased due to RET. Activation of
gp91phox is necessary for the regulation on cytokine secretion via RET-associated mitoROS. Data are from two independent experiments. “n” indicates number of
cells used for quantification; bars indicate means and standard errors, red rhomb represent means. Statistical significance was calculated with the Kruskal-Wallis test
followed by Tukey post-hoc test (B), the Mann Whitney U Test (C), the t-test (D, E): ** indicates p<0.01.March 2021 | Volume 12 | Article 641495
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and mitoROS production (Figure 6F) that is required for the
regulation of antifungal responses in macrophages.DISCUSSION
This study addresses how mitoROS levels in macrophages
orchestrate antimicrobial responses against the major fungal
pathogen A. fumigatus. We found that increased mitoROS levels
are triggered by germinating (swollen) conidia of A. fumigatus, but
not by dormant (resting) conidia. RET contributes to these
mitoROS levels, and this is related to elevated complex II activity
in the respiratory chain and increased mitochondrial membrane
potential. The elevation in mitoROS levels appears to rely on
upstream NOX2-dependent signalling, ultimately leading to the
enhanced production of pro-inflammatory cytokines that include
TNF-a and IL-1b. Together, these results reveal that RET-generated
mitoROS contribute to the antifungal responses of macrophages to
A. fumigatus.
Coenzyme Q binding sites at complex I and complex III are
among major producers of ROS in mitochondria (51). MitoROS
generated at complex III was proposed to regulate cytokine
secretion in Listeria monocytogenes–infected macrophages (52).
Interestingly, in our study, a compound that specifically inhibits
ROS production at coenzyme Q binding site of complex III,
namely S3QEL2 (53), did not alter the ability of macrophages to
inhibit A. fumigatus growth or secrete TNF-a. This suggested
that complex III was not the main source of elevated mitoROS in
fungus-stimulated macrophages.
It has been also proposed that enhanced mitoROS production
via RET at complex I is crucial to transform macrophages into a
pro-inflammatory state upon activation with LPS (9). The
process involves metabolic alterations in the macrophage that
include increased succinate oxidation by complex II, which could
potentially drive mitoROS production via RET (9, 10). Here, we
demonstrate that exposure to swollen A. fumigatus conidia leads
to elevated complex II activity in the infected macrophages, and
to mitoROS formation via RET. Interestingly, fungal viability is
not essential to trigger RET, as formalin-fixed swollen conidia
were sufficient to initiate mitoROS via this pathway. However,
given that heat-killed swollen conidia fail to induce elevated
mitoROS levels, heat-sensitive molecules on the fungal surface,
or the heat-sensitive organization of these molecules on the
surface, seem to trigger RET in the macrophage.
One of the phenotypic outcomes of enhanced mitoROS in
stimulated macrophages is the modulation of cytokine release.
The exact mechanism by which mitoROS affect cytokine secretion
remains unclear. However, we have shown that macrophages
infected with swollen A. fumigatus conidia exhibit increased thiol
oxidation in endogenous proteins. This is consistent with the report
that in L. monocytogenes-infected macrophages, mitoROS modify
the redox status of Nuclear factor-kB (NF-kB) essential modulator,
which regulates the extracellular signal-regulated protein kinases 1
and 2 and NF-kB pathways to promote the synthesis of pro-
inflammatory molecules such as IL1-b, TNF-a and IL-6 (52). InFrontiers in Immunology | www.frontiersin.org 12addition to regulating redox-sensitive regulators of cytokine
secretion, mitoROS may also affect pathways that supply reducing
equivalents, such as NADPH. For instance, mitoROS can cause
reversible oxidative modifications of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), which would result in the diversion of
glycolytic intermediates towards the pentose phosphate pathway to
generate NADPH (54, 55). In addition to providing the reducing
power that fuels antioxidant systems (56), NADPH is also used by
NOX2 to generate antimicrobial phagosomal ROS. The potential
involvement of mitoROS in regulating GAPDH activity, and hence
the supply of reducing equivalents for NOX2, requires
further investigation.
In addition to the potential impact of mitoROS on NOX2
functionality, NOX2 itself directly influences mitoROS production
in activated macrophages. This work confirms there is crosstalk
between NOX2 and mitochondria. In particular, using NOX2-
deficient cells, we have shown that NOX2 activity is required to
triggermitoROS through RET. It is conceivable that, upon infection,
NOX2-derived ROS cause oxidation and activation of the Fgr kinase
leading to enhanced mitochondrial complex II activity, thereby
creating the conditions for RET to take place (10, 57). Alternatively,
the ROS produced by NOX2 may cause depolarization of
mitochondrial membranes, matrix swelling and alkalinization,
thereby leading to elevated mitoROS levels (58–60). Interestingly,
the inhibition of NOX2 complex assembly in the phagosome
membrane by DHN melanin on the conidial surface (61) could
have accounted for the lack of mitoROS production by
macrophages exposed to resting conidia. However, this notion is
not supported by our observation that dormant Dpksp conidia,
which lack DHN melanin, were unable to induce RET in
macrophages. Taken together, these findings indicate that NOX2
activation, in conjunction with the recognition of fungal cell surface
components unique to swollen conidia, are required to initiate RET-
mediated mitoROS redox signalling.
The lack of RET-mediated mitoROS in macrophages after
exposure to resting conidia may explain their limited
inflammatory responses and their ability to preserve immune
homeostasis (62). Upon inhalation of A. fumigatus conidia,
pulmonary immune cells maintain sterilizing immunity by rapid
clearance of these resting conidia (63). The absence of mitoROS
signalling may help to prevent exaggerated immune responses to
dormant conidia that do not pose a significant threat. On the other
hand, we observed an increase in RET-mediated mitoROS
production following the sensing of a more dangerous form of
the fungus - germinating conidia with the potential to cause invasive
disease. Therefore, the regulation of mitoROS production via RET
may be important for scaling immune responsiveness by activating
immune responses to swollen A. fumigatus while preventing
inflammation to dormant conidia.
As well as being important for initiating pro-inflammatory signals,
RET in immune cells might be involved in limiting inflammation and
preventing tissue damage after prolonged stimulation (11, 12). Thus,
it is intriguing to speculate that in NOX2-deficient cells, the absence
of RET might be responsible for dysregulated inflammatory
responses. Indeed, patients with chronic granulomatous disease
(CGD) whose immune cells lack functional NOX2, suffer fromMarch 2021 | Volume 12 | Article 641495
Hatinguais et al. MitoROS Macrophages Antifungal Responsesprolonged inflammatory reactions that can lead to tissue damage (64,
65). Although RET-mediated mitoROS production does not occur in
NOX2-deficient cells, and thus does not contribute into cytokine
induction, our data indicate that redox homeostasis might be
disrupted in these cells due to high mitoROS levels. This would be
consistent with previous studies claiming that the lack of NOX2
results in mitochondrial redox imbalance and oxidative stress (66–
68). In particular, in CGD patients, increased mitoROS levels are
responsible for spontaneous neutrophil extracellular trap formation
and linked to autoimmune disorders (67). Therefore, further
investigations are required to address whether the activation of
RET in immune cells with redox imbalance, such as gp91phox-/-
cells, would help to modulate and normalize dysregulated
inflammatory reactions. To support this possibility, triggering RET
was previously shown to rescue pathogenesis associated with severe
oxidative stress and even to increase Drosophila lifespan (18).
Therefore, the modulation of mitoROS production specifically via
RET might be beneficial in various pathological conditions.DATA AVAILABILITY STATEMENT
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10. Garaude J, Acıń-Pérez R, Martıńez-Cano S, Enamorado M, Ugolini M, Nistal-
Villán E, et al. Mitochondrial respiratory-chain adaptations in macrophages
contribute to antibacterial host defense. Nat Immunol (2016) 17:1037–45.
doi: 10.1038/ni.3509
11. Langston PK, Nambu A, Jung J, Shibata M, Aksoylar HI, Lei J, et al. Glycerol
phosphate shuttle enzyme GPD2 regulates macrophage inflammatory
responses. Nat Immunol (2019) 20:1186–95. doi: 10.1038/s41590-019-0453-7
12. Murphy MP. Rerouting metabolism to activate macrophages. Nat Immunol
(2019) 20:1097–9. doi: 10.1038/s41590-019-0455-5
13. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J
(2009) 417:1–13. doi: 10.1042/BJ20081386
14. Robb EL, Hall AR, Prime TA, Eaton S, Szibor M, Viscomi C, et al. Control of
mitochondrial superoxide production by reverse electron transport at
complex I. J Biol Chem (2018) 293:9869–79. doi: 10.1074/jbc.RA118.003647
15. Scialò F, Fernández-Ayala DJ, Sanz A. Role of mitochondrial reverse electron
transport in ROS signaling: Potential roles in health and disease. Front Physiol
(2017) 8:428. doi: 10.3389/fphys.2017.00428
16. Scialò F, Sriram A, Stefanatos R, Spriggs RV, Loh SHY, Martins LM, et al.
Mitochondrial complex I derived ROS regulate stress adaptation in
Drosophila melanogaster. Redox Biol (2020) 32:101450. doi: 10.1016/
j.redox.2020.101450March 2021 | Volume 12 | Article 641495
Hatinguais et al. MitoROS Macrophages Antifungal Responses17. Fernández-Agüera MC, Gao L, González-Rodrıǵuez P, Pintado CO, Arias-
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19. Gonçalves SM, Duarte-Oliveira C, Campos CF, Aimanianda V, Ter Horst R,
Leite L, et al. Phagosomal removal of fungal melanin reprograms macrophage
metabolism to promote antifungal immunity. Nat Commun (2020) 11:2282.
doi: 10.1038/s41467-020-16120-z
20. Davies JQ, Gordon S. Isolation and Culture of Murine Macrophages in Basic
Cell Culture Protocols (New Jersey: Humana Press) (2005) 091–104.
doi: 10.1385/1-59259-838-2:091
21. Nayak DK, Mendez O, Bowen S, Mohanakumar T. Isolation and in vitro
culture of murine and human alveolar macrophages. J Vis Exp (2018) 57287.
doi: 10.3791/57287
22. Thau N, Monod M, Crestani B, Rolland C, Tronchin G, Latge JP, et al.
rodletless mutants of Aspergillus fumigatus. Infect Immun (1994) 62:4380–8.
doi: 10.1128/iai.62.10.4380-4388.1994
23. Tsai HF, Wheeler MH, Chang YC, Kwon-Chung KJ. A developmentally regulated
gene cluster involved in conidial pigment biosynthesis in Aspergillus fumigatus.
J Bacteriol (1999) 181:6469–77. doi: 10.1128/jb.181.20.6469-6477.1999
24. Guo J, Gaffrey MJ, Su D, Liu T, Camp DG, Smith RD, et al. Resin-Assisted
enrichment of thiols as a general strategy for proteomic profiling of cysteine-based
reversible modifications. Nat Protoc (2014) 9:64–75. doi: 10.1038/nprot.2013.161
25. Friedenauer S, Berlet HH. Sensitivity and variability of the Bradford protein
assay in the presence of detergents. Anal Biochem (1989) 178:263–8.
doi: 10.1016/0003-2697(89)90636-2
26. Spinazzi M, Casarin A, Pertegato V, Salviati L, Angelini C. Assessment of
mitochondrial respiratory chain enzymatic activities on tissues and cultured
cells. Nat Protoc (2012) 7:1235–46. doi: 10.1038/nprot.2012.058
27. Sarker SD, Nahar L, Kumarasamy Y. Microtitre plate-based antibacterial assay
incorporating resazurin as an indicator of cell growth, and its application in
the in vitro antibacterial screening of phytochemicals.Methods (2007) 42:321–
4. doi: 10.1016/j.ymeth.2007.01.006
28. R Development Core Team R. R: A Language and Environment for Statistical
Computing. R Foundation for Statistical Computing. (2011). doi: 10.1007/978-
3-540-74686-7.
29. Fox J, Weisberg S. An {R} Companion to Applied Regression, (top). Thousand
Oaks CA: Sage (2019).
30. Dowle M, Srinivasan A. data.table: Extension of “data.frame”. R Package
Version 1.12.8. Manual. (2019).
31. Ginestet C. ggplot2: Elegant Graphics for Data Analysis. J R Stat Soc Ser A Stat
Soc (2011). doi: 10.1111/j.1467-985x.2010.00676_9.x
32. Kassambara A. "ggpubr": “ggplot2” Based Publication Ready Plots. R Packag
version 025. 2020.
33. Kassambara A. Package "rstatix" R topics documented. (2020).
34. Wickham H. The split-apply-combine strategy for data analysis. J Stat
Software (2011). doi: 10.18637/jss.v040.i01
35. Fox JA, Weisberg S, Price B. CarData: Companion to applied regression data
sets. (2019).
36. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical
and Powerful Approach to Multiple Testing. J R Stat Soc Ser B (1995) 57:289–
300. doi: 10.1111/j.2517-6161.1995.tb02031.x
37. Chouchani ET, Pell VR, James AM,Work LM, Saeb-Parsy K, Frezza C, et al. A
unifying mechanism for mitochondrial superoxide production during
ischemia-reperfusion injury. Cell Metab (2016) 23:254–63. doi: 10.1016/
j.cmet.2015.12.009
38. Guarás A, Perales-Clemente E, Calvo E, Acıń-Pérez R, Loureiro-Lopez M,
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E. The RodA Hydrophobin on Aspergillus fumigatus Spores Masks Dectin-1–Frontiers in Immunology | www.frontiersin.org 14and Dectin-2–Dependent Responses and Enhances Fungal Survival In Vivo.
J Immunol (2013) 191:2581–8. doi: 10.4049/jimmunol.1300748
41. Gersuk GM, Underhill DM, Zhu L, Marr KA. Dectin-1 and TLRs Permit
Macrophages to Distinguish between Different Aspergillus fumigatus Cellular
States. J Immunol (2006) 176:3717–24. doi: 10.4049/jimmunol.176.6.3717
42. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschläger N, Endres S, et al.
Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host
defence. Nature (2009) 459:433–6. doi: 10.1038/nature07965
43. Brand MD, Goncalves RLS, Orr AL, Vargas L, Gerencser AA, Borch Jensen M,
et al. Suppressors of Superoxide-H2O2 Production at Site IQ of Mitochondrial
Complex I Protect against Stem Cell Hyperplasia and Ischemia-Reperfusion
Injury. Cell Metab (2016) 24:582–92. doi: 10.1016/j.cmet.2016.08.012
44. Watson MA, Wong HS, Brand MD. Use of S1QELs and S3QELs to link
mitochondrial sites of superoxide and hydrogen peroxide generation to
physiological and pathological outcomes. Biochem Soc Trans (2019)
47:1461–9. doi: 10.1042/BST20190305
45. Hatinguais R, Willment JA, Brown GD. PAMPs of the Fungal Cell Wall and
Mammalian PRRs in Current Topics in Microbiology and Immunology.
Springer Science and Business Media Deutschland GmbH (2020) pp. 187–
223. doi: 10.1007/82_2020_201.
46. Blander JM, Sander LE. Beyond pattern recognition: Five immune
checkpoints for scaling the microbial threat. Nat Rev Immunol (2012)
12:215–25. doi: 10.1038/nri3167
47. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radical
Biol Med (2011) 51:1289–301. doi: 10.1016/j.freeradbiomed.2011.06.033
48. Daiber A. Redox signaling (cross-talk) from and to mitochondria involves
mitochondrial pores and reactive oxygen species. Biochim Biophys Acta -
Bioenerg (2010) 1797:897–906. doi: 10.1016/j.bbabio.2010.01.032
49. Cross AR, Jones OTG. The effect of the inhibitor diphenylene iodonium on the
superoxide-generating system of neutrophils. Specific labelling of a component
polypeptide of the oxidase. Biochem J (1986) 237:111–6. doi: 10.1042/bj2370111
50. Philippe B, Ibrahim-Granet O, Prévost MC, Gougerot-Pocidalo MA, Perez
MS, Van der Meeren A, et al. Killing of Aspergillus fumigatus by alveolar
macrophages is mediated by reactive oxidant intermediates. Infect Immun
(2003) 71:3034–42. doi: 10.1128/IAI.71.6.3034-3042.2003
51. Brand MD. The sites and topology of mitochondrial superoxide production.
Exp Gerontol (2010) 45:466–72. doi: 10.1016/j.exger.2010.01.003
52. Herb M, Gluschko A, Wiegmann K, Farid A, Wolf A, Utermöhlen O, et al.
Mitochondrial reactive oxygen species enable proinflammatory signaling
through disulfide linkage of NEMO. Sci Signal (2019) 12:eaar5926.
doi: 10.1126/scisignal.aar5926
53. Orr AL, Vargas L, Turk CN, Baaten JE, Matzen JT, Dardov VJ, et al.
Suppressors of superoxide production from mitochondrial complex III. Nat
Chem Biol (2015) 11:834–6. doi: 10.1038/nchembio.1910
54. Godon C, Lagniel G, Lee J, Buhler JM, Kieffer S, Perrot M, et al. The H2O2 stimulon
in Saccharomyces cerevisiae. J Biol Chem (1998) 273:22480–9. doi: 10.1074/
jbc.273.35.22480
55. Shenton D, Grant CM. Protein S-thiolation targets glycolysis and protein
synthesis in response to oxidative stress in the yeast Saccharomyces cerevisiae.
Biochem J (2003) 374:513–9. doi: 10.1042/BJ20030414
56. Mullarky E, Cantley LC. Diverting Glycolysis to Combat Oxidative Stress in Innovative
Medicine (Tokyo: Springer Japan) (2015) pp. 3–23. doi: 10.1007/978-4-431-55651-0_1
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